| Cash Flow | 2025-07-31 |
|---|---|
| Net loss | -79,422 |
| Non-cash interest expense | 645 |
| Non-cash lease expense | -125 |
| Amortization (accretion) of marketable securities | 2,645 |
| Unrealized foreign currency losses | -28 |
| Share-based compensation expense | 7,040 |
| Depreciation of property and equipment | 338 |
| Investment tax credit receivable | 378 |
| Prepaid expenses and other assets | -3 |
| Accounts payable | 970 |
| Accrued expenses and other liabilities | -1,024 |
| Lease liabilities | 43 |
| Net cash used in operating activities | -74,277 |
| Purchases of property and equipment | 1,048 |
| Purchases of marketable securities | 153,095 |
| Proceeds from maturities of marketable securities | 88,505 |
| Net cash used in investing activities | -65,638 |
| Proceeds from exercise of stock options | 232 |
| Repayments of term loan principal | 699 |
| Net cash (used in) provided by financing activities | -467 |
| Effect of exchange rate changes on cash | 1 |
| Net (decrease) increase in cash and cash equivalents | -140,381 |
enGene Holdings Inc. (ENGNW)
enGene Holdings Inc. (ENGNW)